Study summary · research use only
Public Interest in Acetyl Hexapeptide-8: Longitudinal Analysis
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study analyzed Google search-trend data (not an animal or human clinical study) on public interest in acetyl hexapeptide-8 (Argireline), a topical peptide marketed for antiwrinkle effects, in the United States from 2013 to 2023. The authors report that search volume for terms including 'Argireline' and 'Botox in a Bottle' increased substantially in 2022, though 'Argireline' remained less searched than 'Botox,' described as having a stable, up-trending search volume over the past decade. The authors suggest the rising interest may relate to the product's cost, over-the-counter availability, and ease of self-application compared with botulinum neurotoxin injections.
Abstract
Acetyl hexapeptide-8, also known as Argireline, is a topical, short-acting, synthetic peptide that has recently gained popularity for its antiwrinkle effects. This agent has emerged as a more accessible alternative to botulinum neurotoxin. This study evaluates the public interest in acetyl hexapeptide-8 in the United States from 2013 to 2023, as described by search volume on Google, the most-used search engine. We analyzed the longitudinal relative monthly search volume from January 1, 2013, to January 1, 2023, for acetyl hexapeptide-related terms. We compared the internet search trends for "Botox" during this period to "Argireline." The terms "Argireline" and "Botox in a Bottle" both had substantial increases in search volume in 2022. Although its search volume is drastically increasing, "Argireline" was less searched than "Botox," which had a stable, up-trending search volume over the past decade. The increasing interest in acetyl hexapeptide-8 may be due to its cost-effectiveness and use as a botulinum neurotoxin alternative. Affordability, over-the-counter availability, and ease of self-application of the agent suggest its potential to enhance accessibility to cosmetic dermatologic care.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.